Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/11553
DC FieldValueLanguage
dc.contributor.authorOhyashiki, Ken_US
dc.contributor.authorKocova, Men_US
dc.contributor.authorRyan, D Hen_US
dc.contributor.authorRowe, J Men_US
dc.contributor.authorSandberg, A Aen_US
dc.date.accessioned2021-03-25T11:03:59Z-
dc.date.available2021-03-25T11:03:59Z-
dc.date.issued1986-01-15-
dc.identifier.issn0165-4608-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/11553-
dc.description.abstractPh-positive acute myeloblastic leukemia (AML) developing in a treated case of Wegener's granulomatosis is reported. The patient was a 70-year-old white male who received cyclophosphamide (150 mg/day) starting in July 1978; in May 1984 the patient was diagnosed as having AML, following a diagnosis of myelodysplastic syndrome lasting 3 months. Cytogenetic study of bone marrow cells at the diagnosis of the myelodysplastic syndrome revealed a standard Ph translocation in addition to numerical chromosome changes [i.e., 45,XY, -5, -7, -8, +19, +mar/45,XY, -5, -7, -8, +19, +mar,t(9;22)(q34;q11]). The events in this case suggest a strong possibility of the Ph-positive AML being a secondary disease related to prior cyclophosphamide therapy.en_US
dc.language.isoenen_US
dc.publisherELSEVIER SCIENCE INCen_US
dc.relation.ispartofCancer genetics and cytogeneticsen_US
dc.titleSecondary acute myeloblastic leukemia with a Ph translocation in a treated Wegener's granulomatosisen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/0165-4608(86)90062-2-
dc.identifier.volume19-
dc.identifier.issue3-4-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Page view(s)

35
checked on Sep 18, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.